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Background: Hedgehog (Hh) signals are instrumental to the dorsoventral patterning of the vertebrate eye,
promoting optic stalk and ventral retinal fates and repressing dorsal retinal identity. There has been limited
analysis, however, of the critical window during which Hh molecules control eye polarity and of the temporal
changes in the responsiveness of eye cells to these signals.
Results: In this study, we used pharmacological and molecular tools to perform stage-specific manipulations of
Hh signalling in the developing Xenopus eye. In gain-of-function experiments, most of the eye was sensitive to
ventralization when the Hh pathway was activated starting from gastrula/neurula stages. During optic vesicle stages,
the dorsal eye became resistant to Hh-dependent ventralization, but this pathway could partially upregulate optic
stalk markers within the retina. In loss-of-function assays, inhibition of Hh signalling starting from neurula stages
caused expansion of the dorsal retina at the expense of the ventral retina and the optic stalk, while the effects of
Hh inhibition during optic vesicle stages were limited to the reduction of optic stalk size.
Conclusions: Our results suggest the existence of two competence windows during which the Hh pathway
differentially controls patterning of the eye region. In the first window, between the neural plate and the optic
vesicle stages, Hh signalling exerts a global influence on eye dorsoventral polarity, contributing to the specification
of optic stalk, ventral retina and dorsal retinal domains. In the second window, between optic vesicle and optic cup
stages, this pathway plays a more limited role in the maintenance of the optic stalk domain. We speculate that this
temporal regulation is important to coordinate dorsoventral patterning with morphogenesis and differentiation
processes during eye development.
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Vertebrate eye development begins during gastrulation,
when the eye-forming region, known as the eye field, is
induced within the anterior neural plate by signals pro-
duced by the underlying mesendoderm and other sur-
rounding tissues [1-3]. During neurulation, the initially
continuous eye field is split in two bilateral domains that* Correspondence: liuy@moon.ibp.ac.cn
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unless otherwise stated.evaginate from the lateral forebrain walls to form the
optic vesicles [4,5]. Subsequently, invagination of the
optic vesicles gives rise to the optic cups, which differen-
tiate into the retinal pigmented epithelium (RPE), the
neural retina and the optic nerve [6-8].
During these morphogenetic processes, the ventral part
of the optic vesicle forms the optic stalk (OS), which con-
nects the eye with the forebrain and later differentiates
into the glial cells of the optic nerve, while the dorsolateral
regions of the optic vesicle form the neural and pigmented
retina [6,7,9]. This dorsoventral (DV) regionalization in-
volves the differential expression of transcription factorThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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least three domains: the ventrally located OS, expressing
Pax2,Vax1 and Vax2; the presumptive ventral retina (VR),
expressing Vax2 and the presumptive dorsal retina (DR),
expressing Tbx3 and Tbx5 [10-12]. Similar to the spinal
cord, regulation of gene expression along the eye DV axis
depends on the ventralizing influence of hedgehog (Hh)
ligands secreted from midline tissues (rostral mesendo-
derm and ventral forebrain) and the dorsalizing activity of
bone morphogenetic protein (BMP)-like signals (GDF6
and BMP4) secreted from the dorsal pole of the eye bud
and adjacent non-neural ectoderm [13-16].
While studies in zebrafish, Xenopus, chick and mouse
embryos have all shown a role for Hh signalling in the
ventralization of the eye [12,17-19], the developmental
window during which the Hh pathway controls eye DV
patterning and the temporal changes in the response of
eye cells to Hh signals have been only partially investi-
gated. In particular, there is a lack of information on the
function of Hh signalling during the transition between
eye field and optic vesicle stages, which is likely to be a
critical window in the establishment of DV polarity, based
on the dynamic expression patterns shown by relevant
transcription factors [11]. In this study, we therefore used
various molecular tools to activate or inhibit Hh signalling
during specific stages of Xenopus eye development and we
assessed the consequences of these manipulations on the
DV polarity of the eye. All the employed experimental ap-
proaches suggest that the Hh pathway controls global DV
patterning of the eye region, contributing to the specifica-
tion of OS, VR and DR domains, as early as gastrula/
neurula embryonic stages. Concomitantly with the emer-
gence of the optic vesicle, the influence of Hh signalling
on DR and VR fates decreases, as shown by increased re-
sistance of the DR to Hh-dependent ventralization and by
Hh-independent maintenance of VR fates. In contrast, Hh
signalling continues to support OS gene expression during
optic vesicle stages and this prolonged regulatory input is
required for the maintenance of proper OS size.
Results
Upregulation of smoothened-dependent signalling in the
developing Xenopus eye causes stage-dependent effects
on ocular DV patterning
Several studies have shown that Hh signalling plays a cru-
cial role in the specification of ventral ocular fates and that
overexpression of this pathway in the developing eye causes
ventralization of the dorsal eye region [10,12,13,17,18,20].
To gain insight into the developmental window during
which upregulation of Hh signalling can affect eye DV po-
larity, we took advantage of purmorphamine (PMP), a small
molecule agonist of smoothened (Smo), which was previ-
ously shown to activate the Hh pathway in the developing
Xenopus eye [21]. Xenopus embryos were treated with 300to 600 μM PMP starting from different stages, and the
effects on eye DV patterning were scored at early optic
cup stages (st. 33) by whole mount in situ hybridization.
The following molecular markers were used as a read-
out for changes in the eye DV organization of treated
embryos: Pax2 and Vax1b, which are markers of the
OS, the most ventral eye structure; Vax2, which is
expressed both in the OS and in the overlying VR and
Tbx3, a DR marker [11,12].
These experiments showed that activation of Hh sig-
nalling caused two different, temporally distinct, effects
on the DV patterning of the eye. The stronger, and earl-
ier, effect was the ventralization of the dorsal eye region,
with upregulation of ventral eye markers throughout the
eye and downregulation of DR markers. The weaker, and
later, effect was the expansion of OS marker expression
within the ventral, nasal and central retina, while expres-
sion of DR markers remained relatively unaffected. To
quantify these different effects, we assigned an increas-
ing score to PMP-treated embryos hybridized with
probes for the OS markers Pax2 and Vax1b depending
on the extent of their ectopic expression into the dorsal
half of the eye. Embryos in which transcription of OS
markers remained confined within the ventral eye were
given a 0 score. Embryos with limited, discontinuous up-
regulation of these genes into the dorsal eye, usually re-
stricted to the dorsal marginal zone or to small groups
of cells scattered in the dorsal eye, were scored as 1.
Score 2 was assigned to embryos where expression of
OS markers continuously spread from the ventral to the
dorsal eye, but a substantial Pax2/Vax1b-negative dorsal
domain persisted. Finally, embryos with a 3 score were
those where Pax2 or Vax1b expression covered most of
the eye. This analysis was finished off by quantifying the
fractions of embryos where expression of the VR marker
Vax2 spread through most of the eye and that of Tbx3
was strongly reduced, while the rest of the embryos
retained substantial Vax2-negative and Tbx3-positive
domains within the dorsal eye.
PMP treatments started from late blastula/early gas-
trula stages (st. 8/10.5, Figure 1A,B,C) reproduced the
effects of Hh ligand mRNA injections in early embryos
[12], as they could cause upregulation of Pax2, Vax1b
and Vax2 throughout the eye and downregulation of
Tbx3. In these conditions, the majority of treated em-
bryos upregulated Vax2 through most of the eye (73%)
and a similar situation was found also for Pax2 (score 3,
92%). Significant numbers of embryos also expressed
Vax1b in a broad DV domain (score 3, 47%) or showed
severely reduced expression of Tbx3 (22%). The percent-
age of embryos with strong downregulation of Tbx3 in-
creased when PMP treatments were started from early
cleavage stages (st. 4, Additional file 1: Figure S1). When
PMP was delivered from early neurula stages (st. 12.5 to
Figure 1 PMP treatments cause stage dependent effects on eye DV polarity. (A) Lateral views of heads of st. 33 embryos treated with
DMSO (mock) or 300 to 600 μM PMP from the indicated stages and hybridized with probes for Pax2, Vax1b, Vax2 or Tbx3. In mock-treated
embryos, wild-type expression patterns of these genes are detectable: Pax2 and Vax1b staining is restricted to the OS, Vax2-positive region covers
the OS and VR, Tbx3 expression identifies the DR. PMP treatments affect gene expression domains to various degrees depending on the stage of
delivery (st. 8 to 10, blastula-early gastrula; st. 12.5 to 14, late gastrula-early neurula; st. 19 to 22, late neurula-early optic vesicle; st. 26, mid optic
vesicle). For Pax2 and Vax1b, embryos were grouped into 0 to 3 scores (numbers at the bottom right corner of each image) as explained in the
‘Results’ section and representative eyes for each score group are shown. See text for details. The broken yellow circles highlight the eye region.
Scale bar, 200 μm. (B) Quantification of the percentages of embryos stained for Pax2 or Vax1b with 0 to 3 scores in each treatment condition.
Embryos stained for Vax2 or Tbx3 were grouped according to the DV extent of Vax2/Tbx3 expression domain (more or less than 90% of the eye
for Vax2; more or less than 10% of the eye for Tbx3). The percentages of embryos with strong eye reductions are also indicated (S, small eyes).
The number of experiments performed for each probe and treatment condition is indicated on top of the corresponding histogram bar. At
least 20 eyes/10 embryos were analysed for each experiment. (C) Histological sections of eyes of st. 33 embryos treated as in (A) and (B), and
hybridized with the indicated probes, confirming stage dependent alterations in the expression domains of Pax2, Vax1b, Vax2 and Tbx3 as
detected in whole mount views. Scale bar, 100 μm.
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with strong expansion of the Pax2 domain were still de-
tectable (score 3, 59%), but the fractions of embryos with
a broad spread of Vax2 (24%) or Vax1b (score 3, 14%)
were reduced and those with severe Tbx3 reduction were
nearly absent (3%). These conditions also resulted in sig-
nificant numbers of embryos with partial (score 2) dorsal
expansion of Pax2 and Vax1b, so that nearly all of the
Pax2-stained embryos (97%) and roughly half of the
Vax1b-stained embryos (45%) were scored as 2 or 3.
No embryos with Vax2 expression covering most of
the eye or strongly reduced Tbx3 domain were foundfollowing treatments with PMP from late neurula/early
optic vesicle stages (st. 18 to 22, Figure 1A,B,C), and a
substantial DR domain was specified in these conditions.
Pax2, however, was still markedly upregulated by these
later treatments. Although Pax2 expression seldom
spread through most of the eye (score 3, 6%), almost all
the embryos showed a partial dorsal expansion (score 1
or 2, 89%). Vax1b expression domain was also expanded,
albeit only within the ventral half of the eye. Finally, no
evident effects on Vax2, Vax1b or Tbx3 were observed
when PMP was applied from mid optic vesicle stages (st.
25 to 27, Figure 1A,B,C). In contrast, most of the
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topic transcription at the level of the dorsal marginal
zone (score 1, 90%). Double staining with Tbx3 probes
and an anti-Pax2 antibody confirmed that within the
most dorsal retina, PMP treatments started during optic
vesicle stages caused localized Pax2 protein expression
in the dorsal marginal zone, which partially overlapped
with Tbx3 expression (Additional file 2: Figure S2).
These temporally dependent effects were further charac-
terized by real-time PCR analysis on dissected heads from
control and PMP-treated embryos. The Hh pathway direct
target genes Ptc1, Ptc2 and Gli1 were significantly upregu-
lated following any PMP treatment condition, suggesting
that the different effects of early and late treatments were
not due to decreased efficiency of Hh signalling activation
(Figure 2). In contrast, Pax2,Vax1b and Vax2 were signifi-
cantly upregulated by treatments started at st. 8 or st. 13,
but not later (Figure 2), confirming that strong ventraliza-
tion of the dorsal eye requires increased Hh signalling as
early as gastrula/neurula stages.
This temporal analysis was validated by upregulating
Hh signalling in the eye region by means of grafts of
beads soaked in sonic hedgehog (C25II) N-terminusFigure 2 Quantification of gene expression changes following PMP tr
dissected heads following treatments with 600 μM PMP or DMSO from the
conditions in four independent experiments. Error bars show standard dev
according to two-tailed Student’s t-test.(ShhC25II), a bioactive form of the sonic hedgehog
(Shh) protein [22]. ShhC25II beads grafted during early
(st. 20 to 24) or mid (st. 25 to 27) optic vesicle stages
reproduced the effects of PMP treatments during corre-
sponding developmental windows (Figure 3A,B,C). In ei-
ther case, a significant part of the dorsal eye remained
devoid of expression of the VR marker Vax2 in most
of the embryos. Following early optic vesicle grafts, how-
ever, partial dorsal upregulation of OS markers was
clearly detectable, especially along the nasal region
(Pax2, score 2 to 3, 70%; Vax1b, score 2, 25%). Com-
pared to PMP, ShhC25II beads resulted in some embryos
expressing Pax2 within a broad DV domain (score 3,
23%) and Vax1b was also more strongly upregulated by
ShhC25II at these stages of treatment (compare Pax2
and Vax1b charts in Figures 1B and 2B), suggesting that
PMP treatments cause somewhat slower upregulation of
the Hh pathway compared to grafts of ShhC25II beads.
Grafts performed at mid optic vesicle stages (st. 25 to 27)
yielded similar results to PMP treatments, as Vax2 and
Vax1b expression domains remained confined to the ven-
tral eye region, while Pax2 was ectopically expressed in
the dorsal marginal zone.eatments. Real-time PCR quantification of gene expression in st. 33
indicated stages, shown as the mean ratio between PMP and DMSO
iations. *P < 0.05; **P < 0.01; ***P < 0.001; ns, non-significant (P≥ 0.05)
Figure 3 Grafts of ShhC25II-soaked beads reproduce the
stage-dependent effects of PMP treatments on eye DV
patterning. (A) Lateral views of heads of st. 33 embryos that
received a graft of control or ShhC25II-soaked beads next to the
optic vesicle at the indicated stages and hybridized with probes for
Pax2, Vax1b or Vax2. Compared to controls, embryos grafted with
ShhC25II beads show stage-dependent increase in the expression
domains of ventral eye genes. Scale bar, 100 μm. (B) Quantification
of the percentages of embryos with different effects on gene expression
domains or eye reductions (S) in each treatment condition. The number
of experiments performed for each probe and treatment condition is
indicated on top of the corresponding histogram bar. (C) Histological
sections of eyes of st. 33 embryos treated as in (A) and (B) and
hybridized with the indicated probes, confirming stage dependent
effects on DV eye patterning as detected in whole mount views.
Triangles point to ectopic Pax2 expression in the dorsal marginal
zone and arrows to expanded ventral expression domains of Pax2,
Vax1b and Vax2, in embryos grafted ShhC25II beads. Stars indicate
the position of the beads. Scale bar, 100 μm.
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way plays temporally distinct functions during the speci-
fication of the DV polarity of the eye. During gastrula/
neurula stages, Hh signalling may influence DV pattern-
ing throughout the eye region, as both the ventral and
the dorsal eye are sensitive to ventralization by this path-
way. By early optic vesicle stages, the competence of the
DR to ventralization by Hh signalling appears to be
markedly reduced, but this pathway can still increase OS
marker expression in the ventral/central retina and in
selected areas of the dorsal/nasal retina. Thus, at these
later stages, Hh signalling may play a more restricted
role in promoting OS fates within the ventral eye region.Temporally controlled overexpression of active Gli
constructs reveals prolonged sensitivity of OS genes to
Gli-dependent signalling
While both PMP treatments and grafts of ShhC25II-
soaked beads caused effective activation of the Hh path-
way in the eye, these reagents are likely to affect eye
gene expression with some delay after the start of treat-
ment, due to the time needed to build up sufficient
amounts of ligands in the ocular extra-cellular space
and to activate signal transduction within eye cells.
Therefore, to dissect more precisely the time-dependent
functions of Hh signalling in eye DV patterning, we
employed a previously described Gli1 chimeric con-
struct, encoding for a fusion protein of the Gli1 DNA
binding domain with the strong transcriptional activator
domain of VP16 and the dexamethasone (dex)-inducible
glucocorticoid receptor domain (VP16-Gli1-GR) [23]. In
this case, VP16-Gli1-GR mRNA microinjections in early
embryos allow accumulation of the fusion protein in eye
cells, which can be promptly activated by exposing em-
bryos to dex, leading to rapid transcription of target genes
[23,24]. VP16-Gli1-GR mRNA was unilaterally injected
into one dorsal animal blastomere at the eight-cell stage,
and injected embryos were raised to the desired stage for
dex treatment. No effects on eye development or molecu-
lar marker expression were seen in injected embryos in
the absence of dex, while dex delivery during gastrula or
early neurula stages caused strong eye reduction pheno-
types (data not shown). Dex treatments from late neurula/
early optic vesicle stages (st. 19 to 25, Figure 4A,B,C) did
not decrease eye size, but caused partial ventralization of
the dorsal eye (Figure 4A,B,C), as shown by significant
fractions of embryos where most of the eye expressed
Vax2 (30%) or OS markers (Pax2, score 3, 44%; Vax1b,
score 3, 33%) and by moderate reduction of Tbx3 expres-
sion domain. Double staining for Pax2 protein and Tbx3
mRNA expression showed a partial overlap between Pax2
and Tbx3 staining, indicating that the ectopic Pax2-
positive domain extended within the remaining Tbx3-ex-
pressing region (Additional file 3: Figure S3). When dex
was added starting from mid optic vesicle stages (st. 26 to
27, Figure 4A,B,C), few embryos were found where most
of the eye was positive for Vax2 (2%) or for OS markers
(Pax2, score 3, 12%; Vax1b, score 3, 20%), while the ex-
pression domain of Tbx3 was largely unaffected, thus indi-
cating that DR specification was mostly refractory to
ventralization by Gli-mediated signalling by these stages.
OS markers, however, were still significantly upregulated
by these later treatments, and their expression domains
were expanded in the ventral and central retina and, more
dorsally, along the nasal part of the retina and/or in small
groups of cells scattered in the dorsal half of the eye
(Pax2, score 1 to 2, 63%; Vax1b, score 1 to 2, 45%). Finally,
when dex treatments were started at the late optic vesicle/
Figure 4 Overexpression of VP16-Gli1-GR causes stage dependent effects on eye DV polarity. (A) Lateral views of heads of st. 33 embryos
that were unilaterally injected with 250 pg of VP16-Gli1-GR mRNA at the eight-cell stage, treated with dex from the indicated stages and hybridized
with probes for Pax2, Vax1b, Vax2 and Tbx3. Compared to the control side (uninj.), stage-dependent alterations in gene expression domains are
detectable on the injected side. Light-blue β-gal staining identifies the injected side. Scale bar, 200 μm. (B) Quantification of the percentages
of embryos with different effects on gene expression domains or eye reductions (S) in each treatment condition. The number of experiments
performed for each probe and treatment condition is indicated on top of the corresponding histogram bar. (C) Histological sections of eyes of
st. 33 embryos treated as in (A) and (B), and hybridized with the indicated probes, confirming stage dependent gene expression changes as
detected in whole mount views. Scale bar, 100 μm.
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tion of Gli-mediated signalling could still promote ectopic
expression of Pax2 and Vax1b in scattered groups of cells
within the central/dorsal retina (Pax2, score 1 to 2, 40%;
Vax1b, score 1 to 2, 31%). Overall, the effects of VP16-
Gli1-GR overexpression were similar to those of PMP
treatments and ShhC25II bead grafts, but eye cells
remained sensitive to ventralization by VP16-Gli1-GR for
longer time windows compared to PMP or ShhC25II
treatments. In particular, VP16-Gli1-GR overexpression
from late neurula/early optic vesicle stages caused similar
effects to PMP treatments from early neurula stages. Like-
wise, the effects of VP16-Gli1-GR overexpression from
mid or late optic vesicle stages were similar to those of
PMP/ShhC25II treatments from early or mid optic vesicle
stages, respectively.
In these experiments, real-time PCR analysis of gene
expression showed that the Hh pathway direct target
genes Ptc1, Ptc2 and Gli1 were significantly upregulated
by VP16-Gli1-GR overexpression independently of the
stage of dex treatment (Figure 5). In contrast, Vax2 wassignificantly upregulated by dex treatments started from
late neurula/early optic vesicle stages, but not later
(Figure 5). Notably, we detected a significant increase in
the expression levels of the OS markers Pax2 and Vax1b
in all treatment conditions, although the extent of their
upregulation decreased in embryos treated from mid or
late optic vesicle stages (Figure 5). Taken together, these
results suggest that DR cells remain competent to ventra-
lization by Gli-mediated signalling throughout neurula
stages, while activation of this pathway can influence ex-
pression of OS genes within a more restricted eye region
up to the initial stages of optic cup formation.
Hh signalling is required for proper OS and VR
specification during neurula stages and for maintenance
of OS size during optic vesicle stages
We next investigated the requirement of functional Hh
pathway during neurula and optic vesicle stages for
proper eye DV patterning by loss-of-function experi-
ments. To this aim, we downregulated Hh signalling
during different time windows by treating embryos with
Figure 5 Quantification of gene expression changes following
VP16-Gli1-GR overexpression. Real-time PCR quantification of gene
expression in st. 33 heads dissected from controls or from embryos
injected with VP16-Gli1-GR mRNA and treated with dex from the
indicated stages. Results are shown as the mean ratio between
VP16-Gli1-GR-injected and control embryos in six independent
experiments. Error bars show standard deviations. *P < 0.05; **P < 0.01;
ns, non-significant (P≥ 0.05) according to two-tailed Student’s t-test.
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gressively later developmental stages. Control and CPM-
treated embryos were then harvested at st. 33, and the
effects on the expression pattern of ventral and dorsal
eye markers were assessed by in situ hybridization. We
previously showed that CPM can effectively inhibit the Hh
pathway in the developing Xenopus eye [12,25]. Moreover,
real-time PCR analysis demonstrated that the Hh respon-
sive genes Ptc1, Ptc2 and Gli1 were strongly downregulated
by CPM irrespectively of the initial stage of treatment (data
not shown).
When embryos were treated with CPM starting from
late gastrula/early neurula stages (st. 12.5 to 13 Figure 6A,
B,C), changes to the overall DV organization of the eye
were detectable. Vax2 expression domain in the VR was
reduced along the eye DV axis, while Tbx3 domain in the
DR was expanded ventrally (Figure 6A,B). In addition, the
ventrally located OS, marked by Pax2 and Vax1b expres-
sion, was shortened (Figure 6A,B). Furthermore, trans-
verse sections of embryos following whole-mount in situ
hybridization revealed a proximo-distal reduction of Pax2,
Vax1b and Vax2 expression domains in the ventral eyeregion of CPM-treated embryos (Figure 6C). CPM deliv-
ery from late neurula/early optic vesicle stages (st. 19 to
20) did not affect the expression domains of Vax2 and
Tbx3 in the VR and the DR, respectively (Figure 6A,B).
Notably, OS size was still reduced by these later treat-
ments (Figure 6A,B). Finally, no changes on eye DV pat-
terning were detected when CPM was applied starting
from mid optic vesicle stages (stage 26, Figure 6A,B).
These results are consistent with those from overexpres-
sion assays and, together, they support a model where Hh
signalling controls the specification of both the VR and
OS during neurula stages and supports maintenance of
OS size during optic vesicle stages.
Discussion
Hh signalling has a pivotal role in the specification of
ventral positional identities in the eye. Overexpression
experiments in zebrafish, Xenopus and chick embryos all
caused expansion of OS and/or VR at the expense of
DR [12,17,18,20], while zebrafish and mouse mutants
for the Hh ligand Shh or the Hh pahway component
Smo showed loss of ventral eye structures [13,18,19].
Here, we show that Hh signalling differentially controls
eye DV patterning during two distinct temporal win-
dows, one from the neurula to the optic vesicle stages
and the other from the optic vesicle to the optic cup
stages, respectively (Figure 7). During the earlier win-
dow, most of the eye field region was competent to ven-
tralization by the Hedgehog pathway. We noticed,
however, that Hh signalling could upregulate ventral eye
genes more efficiently than it could downregulate dorsal
eye genes. For example, effective repression of dorsal
genes required stronger treatment conditions than those
sufficient to expand ventral gene expression domains.
Moreover, ventralization of dorsal eye tissue in response
to increased Hh signalling was often incomplete, as indi-
cated by partial overlap of ectopic ventral gene expres-
sion with areas retaining expression of dorsal genes.
These observations suggest that Hh signalling may regu-
late ventral and dorsal eye genes independently of each
other. While ventral genes appear to be highly respon-
sive to Hh pathway activation, repression of dorsal genes
may involve additional mechanisms, such as interactions
between Hh and other ventralizing signals [12] and/or
inhibition of BMP signalling [14-16,26]. Following this
earlier window, our results suggest that during forma-
tion of the optic vesicle, DR, VR and OS progenitors dif-
ferentially modify their responsiveness to Hh signalling.
In particular, the presumptive DR loses competence to
Hh-dependent ventralization, VR progenitors maintain
their fates in spite of reduced Hh signalling, but they re-
tain competence to acquire OS fates in response to in-
creased Hh signalling, and OS progenitors continue to
rely on active Hh signalling to maintain their identity.
Figure 6 CPM treatments cause stage dependent effects on eye DV polarity. (A) Lateral views of heads of st. 33 embryos treated with
ethanol (mock) or 100 μM CPM from the indicated stages and hybridized with probes for Pax2, Vax1b, Vax2 or Tbx3. Compared to controls,
CPM-treated embryos show stage-dependent changes in gene expression domains along the anteroposterior (AP; Pax2, Vax1b) or the DV (Vax2,
Tbx3) axes of the eye. Scale bar, 200 μm. (B) Quantification of the mean AP (Pax2, Vax1b) or DV (Vax2, Tbx3) width/height of gene expression
domains, normalized to total width/height of the eye, in the eyes of embryos treated as in (A). The number of eyes analysed for each probe
and treatment condition is indicated within the corresponding histogram bar. Error bars show standard deviations. *P < 0.05; ns, non-significant
(P≥ 0.05) according to two-tailed Student’s t-test. (C) Histological sections of eyes of st. 33 embryos treated with ethanol or CPM from st. 13
and hybridized with the indicated probes. CPM-treated eyes show a reduction of Pax2, Vax1b and Vax2 expression domains along the eye
proximodistal axis. Yellow brackets highlight the proximodistal extent of the whole ventral eye region. Scale bar, 100 μm.
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of Hh signalling with different pharmacological and mo-
lecular tools. In particular, we took advantage of small
molecule Smo agonists (PMP) or antagonists (CPM) to ac-
tivate/inhibit Smo-mediated signal transduction during
specific time windows. ShhC25II-soaked beads were used
to confirm the specificity of these pharmacological ap-
proaches. Finally, previously described hormone-inducible
Gli1 constructs [23] were employed for controlled activa-
tion of Hh signalling downstream of Smo. Similar results
were obtained following PMP treatments or grafts of
ShhC25II-soaked beads close to the optic vesicle. How-
ever, the rate of diffusion of these reagents within the
extra-cellular space, and the time needed for intra-cellular
transduction of Smo activation, may potentially delay
the window of effective upregulation of the Hh pathway
compared to the onset of treatment. The previously
characterized dex-inducible Gli1 fusion construct (VP16-
Gli1-GR), which directly activates Hh target genes follow-
ing induction [23], appeared to act more rapidly. Yet,
experiments with PMP, ShhC25II beads and VP16-Gli1-
GR all led to congruent results, which were mirrored byloss-of-function experiments with CPM. The partial re-
duction of VR and/or OS gene expression that we ob-
served following Smo antagonism is consistent with
previous studies [12,25], where it was explained with the
partially redundant roles of Hh, retinoic acid (RA) and
fibroblast growth factor (FGF) pathways in the DV pat-
terning of the Xenopus eye [12].
These results, showing differential temporal changes
in eye cell competence based on DV position, suggest a
possible mechanism to avoid that retinal DV patterning
is perturbed by the later release of Hh signals by differ-
entiating retinal ganglion cells (RGCs) and the RPE,
which regulate the retinal differentiation programme by
activating the Hh pathway within the inner retinal layers,
in the marginal zone and in the RPE, at the level of both
the dorsal and the ventral optic cup, as previously de-
scribed [25,27,28]. On the other hand, prolonged reli-
ance of OS gene expression on Hh signalling during
optic vesicle stages may be associated with the dynamic
expression patterns of OS genes during the transition
from the eye field to the optic cup and to the relatively
























Figure 7 Proposed model of the stage dependent effects of Hh
signalling in the DV patterning of the Xenopus eye. (A) During
gastrula/neurula stages of development, Hh signalling controls the
specification of both the OS and VR domains by promoting
expression of OS (Pax2, Vax1b) and VR (Vax2) genes and repressing
expression of DR genes (Tbx3, Tbx5). (B) During optic vesicle stages,
the expression domains of Vax2 and Tbx3/5 become less dependent
on Hh signalling (dashed lines), which is required to maintain Pax2
and Vax1b expression and proper OS development. At both stages,
activation of Hh signalling is likely to depend on the Shh ligand,
acting through inhibition of Gli repressor proteins (Gli-R) and
increase of Gli activator proteins (Gli-A) [40]. Vax2 was previously
shown to self-activate its own expression at optic vesicle stages [29].
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opment, for example, Pax2 expression domain in the
neural plate eye field largely overlaps with that of Vax2,
extending well within the prospective ventral retina. The
Pax2-positive eye region then progressively recedes to-
wards the ventral midline, but it still embraces Vax2-
positive presumptive ventral retina at early optic vesicle
stages and only during optic cup formation its lateral
limit becomes coincident with the boundary between the
OS and the retina [11]. This dynamic, Hh-dependent
regulation of OS gene expression may be important to
coordinate positioning of the OS/retinal boundary with
the complex morphogenetic processes forging eye field
cells into the optic vesicle and eventually into the optic
cup and stalk.
What could be the molecular mechanisms controlling
the temporal changes in the response of retinal cells to
Hh signalling? The fact that forced expression of active
Gli constructs cannot ventralize the DR during mid/late
optic vesicle stages, reproducing the effects of treat-
ments with PMP/ShhC25II-soaked beads, rules out the
possibility that these changes simply depend on DR cellsbecoming unable to transduce Smo-mediated signalling at
later stages of eye development. This would also be incon-
sistent with the later roles of RGC- and RPE-derived Hh
signals in retinal differentiation. Instead, we suggest that
eye cells remain responsive to Hh signalling but modify
the ability of this pathway to regulate DV patterning genes
using both intrinsic and extrinsic mechanisms. For ex-
ample, epigenetic mechanisms may modify access of Gli
factors to VR and DR gene chromatin during optic vesicle
stages. In addition, Vax2 ability to self-activate its own ex-
pression [29] could contribute to make ventral retinal
identity independent of Hh signalling after its initial estab-
lishment. Furthermore, collaboration with RA and FGF
pathways may increase sensitivity of eye field cells to Hh
signalling during neurula stages [12], while increased ex-
pression of BMP-like molecules (GDF6, BMP4, and so on)
within the dorsal optic vesicle is likely to provide an effect-
ive barrier against Hh-dependent ventralization at later
stages [16]. Clearly, more work is needed to unravel the
interplay between intrinsic and extrinsic mechanisms in
regulating the response of eye cells to Hh signalling.
Temporal changes in the competence of the responding
tissues have been shown to play key roles in Hh-dependent
DV patterning in other neural tube locations, such as the
spinal cord and telencephalon [30-33]. In these regions,
however, Hh-dependent specification of the most ventral
domain is restricted to an early temporal window, whereas,
in the developing eye, the most ventral ocular fates (OS)
show prolonged reliance on Hh signalling. In future work,
it will be interesting to investigate whether eye cells carry
out stage-dependent modifications in the responsiveness to
Hh signalling using similar or distinct mechanisms to those
acting at different levels of the neural tube.
Conclusions
In Xenopus, Hh signalling controls the establishment of
the DV polarity of the eye and the specification of OS, VR
and DR domains during a developmental window mainly
limited to gastrula/neurula stages. This window is defined
by temporal changes in the competence of presumptive
DR cells, which become refractory to Hh-dependent ven-
tralization during optic vesicle stages. At these stages,
however, Hh signalling continues to be required in the
ventral eye region for the maintenance of the OS domain.
In line with previous studies in the telencephalon and the
spinal cord [30-33], these results suggest that coordination
of neural tube patterning and morphogenesis relies on
stage-dependent regulation of morphogen signalling.
Methods
Xenopus embryos and treatments with PMP, CPM or
ShhC25II-soaked beads
Embryos were obtained from Xenopus laevis frogs (Nasco,
Atlanta, GA, USA) by in vitro fertilization at facilities at
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sity of Cambridge (Cambridge, UK), raised and staged as
previously described [34]. For PMP treatments, a 60 mM
stock solution of PMP (Calbiochem, San Diego, CA, USA)
in DMSO was diluted to 300 to 600 μm in 0.1× Marc’s
modified Ringer’s (MMR). For CPM treatments, a 10 mM
stock solution of CPM (Sigma-Aldrich, St. Louis, MO,
USA) in 100% ethanol was diluted to 100 μM in 0.1×
MMR. Embryos were incubated in these solutions at 22°C
in the dark and allowed to grow to the desired stage. Con-
trol sibling embryos were cultured in parallel to PMP- or
CPM-treated embryos in 0.1× MMR containing equivalent
concentrations of DMSO or ethanol. ShhC25II-soaked
beads were prepared using heparin-coated acrylic beads
(diameter <100 μM; Sigma-Aldrich, St. Louis, MO, USA),
which were washed in phosphate buffer saline (PBS)
and soaked overnight at 4°C in a 0.5 μg/μl solution of re-
combinant mouse Sonic hedgehog (C25II), N-terminus
(ShhC25II; R&D Systems, Minneapolis, MN, USA) and
1 μg/μl bovine serum albumin (BSA) in sterile PBS. Con-
trol beads were soaked in a 1.5 μg/μl solution of BSA in
PBS. Embryos were anaesthetized in 0.15% MS222
(Sigma-Aldrich, St. Louis, MO, USA) in 0.1× MMR, trans-
ferred to 0.1× MMR and grafted with ShhC25II or control
beads through a small slit made on one side of the optical
vesicle by sharp forceps. After healing, embryos were
cultured in 0.1× MMR to the desired stage. All animal
work was approved by the Animal Welfare and Biological
Research Ethics Committee at the Institute of Biophysics,
Chinese Academy of Sciences (reference number SYXK2014-
30) and performed in accordance with the Guide for
the Care and Use of Laboratory Animals of the National
Institute of Health (China).
RNA methods and microinjections
The VP16-Gli1-GR plasmid, encoding for a fusion protein
of Gli1 DNA binding domain with the VP16 transcriptional
activation domain and the glucocorticoid receptor (GR) lig-
and binding domain, was previously described [23]. Capped
mRNAs were synthesized and microinjected into one dor-
sal animal blastomere of eight-cell stage embryos as previ-
ously described [35]. For identification of the injected side,
embryos were co-injected with β-galactosidase mRNA and
stained as previously described [12].
Whole mount in situ hybridization and real-time PCR
For in situ hybridization, embryos were fixed in MEMFA
and processed following previously published protocols
[36]. Sectioning of whole mount hybridized embryos was
carried out as previously described [11]. Double staining
for Pax2 protein and Tbx3 mRNA expression was per-
formed on sections (10 μm) from paraffin embedded
embryos by fluorescent in situ hybridization with Tbx3
probes, followed by immunohistochemistry with an anti-Pax2 antibody (Abcam, Cambridge, UK) as second anti-
body, as previously described [37]. For real-time PCR
analysis, total RNA was extracted from dissected heads
of st. 33 embryos, retro-transcribed and amplified on a
Rotor-Gene Q (Qiagen, Hilden, Germany) using Qiagen
kits as previously described [38]. Relative gene expression
levels in different samples were determined with the Rela-
tive Standard Curve Quantification method [39] using H4
[1] as a normalizer. Primers for real-time PCR were de-
signed using Primer3 (http://bioinfo.ut.ee/primer3/) and
are available on request. Statistical analysis of experimen-
tal data was performed with Microsoft Excel software.
Additional files
Additional file 1: Figure S1. PMP treatments from early cleavage
stages repress Tbx3 expression. (A-D) Lateral views of the whole embryos
(A and B) and eyes (C and D) of representative st. 33 embryos that were
treated with DMSO (mock) or 300 μM PMP from the 8-cell stage (st. 4)
and hybridized with probes for Tbx3, showing that early PMP treatments
can strongly downregulate Tbx3 expression in the DR. Scale bars, 1 mm
for (A) and (C), and 0.1 mm for (B) and (D). (E) Quantification of the
percentages of embryos grouped according to the DV extent of Tbx3
expression domain (more or less than 10% of the eye). S, small eyes. The
number of embryos analysed for each treatment condition is indicated
on top of the corresponding histogram bar.
Additional file 2: Figure S2. Ectopic Pax2 protein expression in the
dorsal marginal zone of PMP-treated embryos. Histological sections of
eyes of st. 33 embryos that were treated with DMSO (mock) (A and D)
or 300 μM PMP (E-H, E’-H’) from stage 20, and double-stained by
fluorescent in situ hybridization with Tbx3 probes (red signal), followed
by immunohistochemistry with an anti-Pax2 antibody (green signal). Cell
nuclei were stained with Hoechst (blue signal). PMP treatments started
from optic vesicle stages cause localized ectopic expression of Pax2
protein at the level of the dorsal marginal zone, which partially overlaps
with Tbx3-expression. Enlarged pictures (E’-H’) are higher magnification
images of boxed areas in (E-H), corresponding to the dorsal eye. Scale
bars, 100 μm for (A-H), and 50 μm for (E’-H’).
Additional file 3: Figure S3. Ectopic Pax2 expression within
Tbx3-positive dorsal eye regions following VP16-Gli1-GR overexpression.
Histological sections of control (A-D) or injected (E-H, E’-H’) eyes of
st. 33 embryos that were unilaterally injected with 250 pg of VP16-Gli1-GR
mRNA at the eight-cell stage, treated with dex from st. 22, and double-stained
for Pax2 protein (green signal) and Tbx3 mRNA expression (red signal). Cell
nuclei were stained with Hoechst (blue signal). Following VP16-Gli1-GR
overexpression, ectopic Pax2 protein expression is detectable in the dorsal
eye, where it partially overlaps with Tbx3 expression. Enlarged pictures (E’-H’)
are higher magnification images of boxed areas in (E-H), corresponding to
the dorsal eye. Scale bar, 100 μm for (A-H), and 20 μm for (E’-H’).
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